Managing Incidental Findings with CME/SA-CME Credit

Course Directors: Jonathan Kruskal, MD, PhD, Christine Menias, MD, and Sanjeev Bhalla, MD


This book offers 20 AMA Category 1 Credits™ and 20 American Board of Radiology©, MOC Part II, Self-Assessment CME (SA-CME) following completion of an online test. Soft bound book; 286 pages; 40 chapters.


Module 1 — Liver Imaging — 2.0 SA-CME Credits
Module 2 — Pancreaticobiliary — 2. 0 SA-CME Credits
Module 3 — Abdomen — 2. 0 SA-CME Credits
Module 4 — Genitourinary Imaging — 2. 0 SA-CME Credits
Module 5 — Gynecology — 2.0 SA-CME Credits
Module 6 — Lung Imaging — 2.0 SA-CME Credits
Module 7 — Chest Imagingg — 2.0 SA-CME Credits
Module 8 — Musculoskeletal Imaging — 2.0 SA-CME Credits
Module 9 — Pediatric Imaging — 2.0 SA-CME Credits
Module 10 — General Radiology — 2.0 SA-CME Credits

Target Audience:
This course is intended for all professionals involved in radiology with a particular emphasis on practicing radiologists, and trainees in radiology. A Practical and Current Approach for Managing Incidental Findings is specifically aimed at how incidental findings should be managed.

Statement of Need:
Changes brought about by healthcare reform are having many major impacts on the practice and economics of imaging. Central to this is the need to transform from the pay-for-service to value adding paradigm. One important component of adding value is only doing what is appropriate and safe, and this will soon be linked to a federal mandate and reimbursement. Directly related to this requirement, managing incidental likely asymptomatic imaging findings has become the relevant theme driving metrics for efficiency and appropriateness.

Goals and Objectives:
After completing this course, the learner should be able to:
  1. Identify and characterize relevant incidental findings.
  2. Provide contemporary evidence-based solutions for how incidental findings should be managed.
  3. Appropriately communicate recommendations for follow-up.


Disclosure of Commercial Interest:
ARRS staff involved with this activity have nothing to disclose. Below is a listing of activity's contributors and planners disclosures:
  • J. Kruskal is the recipient of a stipend and an author for Up-To-Date, Inc.
  • C. Menias has nothing to disclose.
  • S. Bhalla has nothing to disclose.
Module 1
  • R. Gupta is a consultant for, and a recipient of honoraria, from Bayer Pharma AG, Invivo Corp., Siemens, and Halyard Health. He is also a member of Bayer Pharma AG’s Speakers Bureau.
  • J. Kruskal is the recipient of a stipend and an author for Up-To-Date, Inc.
  • S. Venkatesh has nothing to disclose.
  • T. Desser has nothing to disclose.
  • A. Sekhar has nothing to disclose.
Module 2
  • J. Soto is an editor with Elsevier.
  • K. Mortele has nothing to disclose.
  • B. Siewert has nothing to disclose.
  • K. Talati has nothing to disclose.
  • J. Steinkeler has nothing to disclose.
  • Y. Wang has nothing to disclose.
Module 3
  • J. Leyendecker has nothing to disclose.
  • M. Taffel has nothing to disclose.
  • M. Lubner is a primary investigator and the recipient of grant funding from Philips, and Ethicon.
  • D. Kim is a co-founder and cop-owner of VirtuoCTC; the recipient of stock options and a member of the medical advisory board for Digitalartforms; and an investor and recipient of stock from Cellectar.
  • E. Silver has nothing to disclose.
  • J. Ogdec has nothing to disclose.
Module 4
  • N. Hindman has nothing to disclose.
  • Z. Wang has nothing to disclose.
  • K. Elsayes has nothing to disclose.
  • S. Verma has nothing to disclose.
  • S. Rothan has nothing to disclose.
  • M. Habra has nothing to disclose.
  • S. Yacob has nothing to disclose.
  • J. Ou has nothing to disclose.
Module 5
  • D. Baumgarten has nothing to disclose.
  • K. Maturen has nothing to disclose.
  • M. Horrow has nothing to disclose.
  • E. Hecht has nothing to disclose.
  • S. Laifer-Narin has nothing to disclose.
  • D. Wahl has nothing to disclose.
  • S. Rodgers has nothing to disclose.
  • M. Sakala has nothing to disclose.
Module 6
  • J. Ko is the recipient of an honorarium and a speaker for Siemens AG.
  • B. Elicker has nothing to disclose.
  • S. Bhalla has nothing to disclose.
  • S. Desai has nothing to disclose.
  • S. Copley has nothing to disclose.
Module 7
  • B. Little has nothing to disclose.
  • K. Cummings has nothing to disclose.
  • S. Patel has nothing to disclose.
  • G. Gladish has nothing to disclose.
  • E. Lee has nothing to disclose.
  • C. Jokerst has nothing to disclose.
Module 8
  • M. Kransdorf has nothing to disclose.
  • M. Murphey has nothing to disclose.
  • J. Baker has nothing to disclose.
  • J. Ni Mhuircheartaigh has nothing to disclose.
  • J. Wu has nothing to disclose.
  • J. Long has nothing to disclose.
Module 9
  • E. Lee has nothing to disclose.
  • G. Schooler has nothing to disclose.
  • R. Ayyala has nothing to disclose.
  • V. Ho has nothing to disclose.
  • A. Winant has nothing to disclose.
Module 10
  • A. Kamaya has nothing to disclose.
  • C. Wu is an author and the recipient of royalties from Elsevier.
  • R. Lamba has nothing to disclose.
  • E. Akin has nothing to disclose.
  • S. McDermott has nothing to disclose.
  • T. Loehfelm has nothing to disclose.
  • M. Corwin has nothing to disclose.
  • M. Aulakh has nothing to disclose.


Member Price:
$80.00
NonMember Price:
$200.00